Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,923,078
in 11 filings, $11.2M under 10b5-1 plans

Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MIGNONE ROBERTO −$14.4M Director sold 100% of stake
  2. Francis Richard D −$10.6M President and CEO sold 21% of stake
  3. Sabag Mark −$3.9M See "Remarks" sold 53% of stake
  4. Daniell Richard −$1.9M EVP, Europe Commercial sold 45% of stake
  5. Weiss Amir −$1.1M Chief Accounting Officer sold 88% of stake
Date Insider Transaction Shares Price Value Owned after
2018-03-19 McClellan Michael James EVP, Chief Financial Officer Sale −287 $17.88 $5K 11,295.27
2018-03-19 Griffin Deborah A Chief Accounting Officer Sale −943 $17.88 $17K 0
2018-03-19 Fridriksdottir Hafrun Executive VP, Global R&D Sale −257 $17.88 $5K 7,141.51
2018-03-19 Fridriksdottir Hafrun Executive VP, Global R&D Sale −91 $17.88 $2K 7,050.51
2018-03-19 Dethlefs Sven EVP Global Marketing&Portfolio Sale −571 $17.88 $10K 4,444.7
2018-03-19 Daniell Richard Exec. VP, European Commercial Sale −1,297 $17.89 $23K 0
2018-03-17 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +2,358 5,332.39
2018-03-17 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −2,358 4,717
2018-03-17 O'Grady Brendan P. EVP, North America Commercial Option exercise +1,179 2,567.49
2018-03-17 O'Grady Brendan P. EVP, North America Commercial Option exercise · Restricted Share Units −1,179 2,358
2018-03-17 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise +872 6,203.36
2018-03-17 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise · Restricted Share Units −872 1,746
2018-03-17 McClellan Michael James EVP, Chief Financial Officer Option exercise +660 11,582.27
2018-03-17 McClellan Michael James EVP, Chief Financial Officer Option exercise · Restricted Share Units −660 1,321
2018-03-17 Griffin Deborah A Chief Accounting Officer Option exercise +943 943
2018-03-17 Griffin Deborah A Chief Accounting Officer Option exercise · Restricted Share Units −943 1,887
2018-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +747 7,133.51
2018-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +265 7,398.51
2018-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −747 1,495
2018-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −265 531

Page 72 of 76 · 1,517 trades